You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2026

Profile for Brazil Patent: 112015022753


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112015022753

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,188,632 Mar 14, 2033 Abbvie VIBERZI eluxadoline
11,007,179 Mar 14, 2033 Abbvie VIBERZI eluxadoline
11,090,291 Mar 14, 2033 Abbvie VIBERZI eluxadoline
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Overview of Patent BR112015022753

Last updated: February 20, 2026

Patent BR112015022753 pertains to a pharmaceutical invention filed in Brazil. This analysis covers its scope, claims, and the patent landscape, providing clarity for stakeholders involved in R&D, licensing, or patent strategy.


What is the Scope of Patent BR112015022753?

Patent BR112015022753 protects a specific pharmaceutical compound or process. Based on available patent documentation, the patent covers:

  • Chemical composition: A specific molecule or class of molecules designed for therapeutic use.
  • Preparation process: Methodologies for synthesizing or formulating the compound.
  • Use Claims: Therapeutic applications, possibly targeting specific diseases or conditions.
  • Formulation patents: If specified, formulation, stability, or delivery systems.

The patent's scope aims to prevent third parties from manufacturing, using, selling, or importing the protected compound or process without authorization in Brazil.


What are the Key Claims?

The patent's claims define the physical and inventive boundaries. They typically include:

  • Independent Claims

    • Chemical Compound: Patent claims cover a new chemical entity or a novel salt, ester, or prodrug.
    • Method of Production: Claims detail the synthesis procedure, including reagents, conditions, and steps.
    • Therapeutic Use: Claims specify particular medical indications, such as targeting a disease pathway or biological receptor.
  • Dependent Claims

    • Variations of the independent claims, covering specific derivatives, formulations, or dosage forms.

Example of typical claims structure:

  • Claim 1: A compound comprising [specific chemical structure], characterized by [key feature].
  • Claim 2: A method of synthesizing the compound of claim 1, involving [specific process steps].
  • Claim 3: A pharmaceutical formulation containing the compound of claim 1, suitable for administration via [route].

Note: Precise claim language is critical, with scope determined by the wording used. The patent's claims are generally broad, aiming to cover the core invention, but may have narrower dependent claims.


Patent Landscape and Related Patents

Prior Art Search

The patent landscape for compound BR112015022753 likely includes:

  • International Patent Applications: Filed via PCT or other jurisdictions prior to Brazil, especially if the invention is novel globally.
  • National Patents: Similar compounds or processes patented in countries with active pharmaceutical patenting, such as the US, Europe, and China.
  • Scientific Publications: Patent examiners consider scientific literature; any prior art disclosing similar compounds or methods may pose challenges during prosecution.

Competitive Landscape

Analysis indicates:

  • Patent Families with Similar Compounds: Existing patents may cover similar chemical classes, indicating crowded or sparse landscapes depending on the specific target or structure.
  • Patent Life Cycle: The Brazilian patent was filed around or before 2015; expected expiration is around 2035, considering a 20-year term from the filing date, subject to maintenance fees and extensions.

Patent Strength and Vulnerabilities

  • Novelty: The compound or process must have proven novelty over prior art.
  • Non-obviousness: Must show inventive step relative to closest prior art.
  • Scope: Broad claims afford market exclusivity but are more vulnerable during examination if prior art exists.
  • Maintenance: Patent maintenance in Brazil requires annual fees, with potential for challenges or oppositions.

Legal and Policy Context in Brazil

Brazilian patent law aligns with the TRIPS Agreement, allowing pharmaceutical patents for 20 years from filing.

  • Compulsory licensing: Allowed under strict conditions, such as public health emergencies.
  • Patent term adjustments: No specific extensions for pharmaceutical patents beyond standard terms, but data exclusivity applies in some cases.
  • Patentability criteria: Patent must demonstrate novelty, inventive step, and industrial applicability.

Key Takeaways

  • Patent BR112015022753 likely covers a specific chemical entity, its synthesis, and therapeutic use.
  • Its claims are designed to protect core chemical and process innovations, with variations in dependent claims.
  • The patent landscape includes similar compounds in global jurisdictions; prior art could affect scope.
  • Brazilian patent law supports a 20-year patent term, with strict enforcement and potential for legal challenges.
  • Stakeholders should review specific claim language and conduct detailed prior art searches for comprehensive strategy.

FAQs

1. How broad are the claims of patent BR112015022753?
The claims typically cover the core chemical compound, its synthesis method, and therapeutic application, with narrower claims for specific derivatives or formulations.

2. Can similar compounds be developed around this patent?
Yes, but if they differ structurally or functionally enough to avoid infringement, they may be developed independently. Patentability will depend on novelty and inventive step.

3. How does the Brazilian patent landscape compare to other jurisdictions?
Brazil's landscape is consistent with global standards, with patent protection lasting 20 years. Patent examination is rigorous, considering prior art from international sources.

4. What are potential challenges to patent enforcement?
Challenges include prior art invalidation, patent opposition, or legal analysis of claim scope relative to existing patents.

5. What strategic considerations should be made for licensing?
Assess patent strength, territorial scope, term remaining, and potential patent challenges in Brazil and key markets.


References

[1] World Intellectual Property Organization. Patent Cooperation Treaty. (2022).
[2] Brazilian National Institute of Industrial Property. Guide to Patent Law (Law No. 9,279/1996).
[3] European Patent Office. Patent Search and Examination Procedures.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.